CMEF, the biggest fair of medical devices, related products and services in Asia, has come to its 40th anniversary. Hangzhou Singclean medical, aiming to be the leader of Chinese absorbable medical devices manufacturer, participated in CMEF Spring 2019 in Shanghai.
From May 14 to May 17 2019, Singclean has attracted visitors and buyers from China and all over the world, showing them the outstanding products including Singclean® Anti-adhesion Gel, Sugiclean® Absorbable Hemostasis Particles and Singfiller® Hyaluronate Acid Dermal Filler. Hangzhou Singclean recently attended meetings to revise industry standards for Sugiclean® Absorbable Hemostasis Particles and Singfiller® Hyaluronate Acid Dermal Filler in China and only the market leader producing high-quality products can get the invitations. Professional visitors often marvel at Hangzhou Singclean's innovation and creativity.
With more and more pioneer products reaching high standard, Hangzhou Singclean is on its way to be the leader of absorbable medical devices, and make its brand a national famous sign of Chinese wisdom made.
-
singclean | 2019-05-17Singclean Draws Major Attention at ESCRS 2025 with Advanced Viscoelastic Solution for Ophthalmic SurgeryCOPENHAGEN, DENMARK – Hangzhou Singclean Medical Products Co., Ltd. made a strong impression at the 45th ESCRS Congress (European Society of Cataract and Refractive Surgeons), held September 12–16, 2025, at the Bella Center in Copenhagen. Recognized globally for its high professional standards and influence in ophthalmology, the congress gathered leading industry manufacturers, surgeons, and specialists from around the world.
-
singclean | 2019-05-17Singderm Filler Achieves 92.7% Efficacy at 12 Months in Global Clinical Trial, Validated by Landmark Thailand MasterclassBangkok, Thailand – Singderm, a globally certified dermal filler brand, has demonstrated unprecedented clinical performance in its Thailand Masterclass led by renowned physician Dr. Worawat Nolah. Three top KOLs (Hack Anantaya, Chalidaorn PinNy, Thantaya Thuranuch) received multi-zone injections with zero complications, reinforcing Singderm’s 92.7% 12-month efficacy rate from a 100-subject clinical trial.
-
singclean | 2019-05-17Singclean to Showcase Innovative Medical Solutions at Key International Exhibitions in Bangkok and Copenhagen